Supporting the designation of the month of May as "Lyme and Tick-borne Disease Awareness Month".

Overview

• Bill: H.Res. 1279
• Session: 119th Congress
• Title: Supporting the designation of the month of May as “Lyme and Tick-borne Disease Awareness Month”
• Type: House resolution (not a bill that would become law)
• Introduced: May 13, 2026
• Primary sponsor: Mr. Smith (NJ); co-sponsors include Mr. Doggett, Mr. Fitzpatrick, Mr. Gottheimer, and Mr. Mackenzie
• Referral: Committee on Energy and Commerce

Purpose and Intent

• Declares House support for designating May as “Lyme and Tick-borne Disease Awareness Month.”
• Seeks to champion awareness efforts and support development of improved clinical responses to Lyme disease and other tick-borne illnesses.
• Aims to emphasize the importance of early detection, treatment, and public health preparedness to monitor and combat outbreaks.

Key Provisions and Provisions’ Implications

• Formal designation: Encourages and supports observance of Lyme and tick-borne disease awareness during the month of May.
• Public health emphasis: Highlights ongoing federal efforts to address Lyme disease through surveillance, education, and response coordination.
• Recognition of existing federal actions:
  • Acknowledges the Kay Hagan Tick Act as establishing a national strategy to combat Lyme disease.
  • Notes the 2023–2024 federal activity, including DHHS roundtables and the LymeX Innovation Accelerator (public-private partnership).
  • Mentions the “No Time for Lyme” public awareness campaign.
• No new mandatory funding, regulatory changes, or statutory mandates are attached to this resolution. As a resolution, it expresses the sentiment and does not create enforceable requirements.

Who/What Would Be Affected

• Affects: Members of the U.S. House of Representatives and the broader public by signaling support for Lyme and tick-borne disease awareness efforts.
• Public health communities: Reinforces federal emphasis on awareness, education, and improved clinical responses.
• Stakeholders (explicitly mentioned in reasoning): Public health officials, researchers, educators, advocates, and federal agencies involved in Lyme disease monitoring and response.

Procedural and Timeline Aspects

• Status: Referred to the House Committee on Energy and Commerce on May 13, 2026.
• No accompanying appropriations or timelines required by the resolution.
• As a resolution, its passage would symbolize congressional support and could influence ongoing or future public messaging and interagency coordination, but it does not mandate specific actions or funding.

Practical Takeaways

• The resolution signals congressional backing for May as Lyme and Tick-borne Disease Awareness Month.
• It aligns with prior legislative and federal efforts to bolster surveillance, public education, and clinical readiness for Lyme disease.
• Readers should note the distinction between a resolution (non-binding, symbolic) and a law that would authorize funding or create new requirements.